BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

539 related articles for article (PubMed ID: 12558800)

  • 21. Potentiation of insulin-stimulated glucose transport by the AMP-activated protein kinase.
    Ju JS; Gitcho MA; Casmaer CA; Patil PB; Han DG; Spencer SA; Fisher JS
    Am J Physiol Cell Physiol; 2007 Jan; 292(1):C564-72. PubMed ID: 16870829
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Resistin promotes cardiac hypertrophy via the AMP-activated protein kinase/mammalian target of rapamycin (AMPK/mTOR) and c-Jun N-terminal kinase/insulin receptor substrate 1 (JNK/IRS1) pathways.
    Kang S; Chemaly ER; Hajjar RJ; Lebeche D
    J Biol Chem; 2011 May; 286(21):18465-73. PubMed ID: 21478152
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of the mTOR/p70S6K pathway is not involved in the insulin-sensitizing effect of AMPK on cardiac glucose uptake.
    Ginion A; Auquier J; Benton CR; Mouton C; Vanoverschelde JL; Hue L; Horman S; Beauloye C; Bertrand L
    Am J Physiol Heart Circ Physiol; 2011 Aug; 301(2):H469-77. PubMed ID: 21602475
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Akt activation protects pancreatic beta cells from AMPK-mediated death through stimulation of mTOR.
    Cai Y; Wang Q; Ling Z; Pipeleers D; McDermott P; Pende M; Heimberg H; Van de Casteele M
    Biochem Pharmacol; 2008 May; 75(10):1981-93. PubMed ID: 18377870
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Toxin-induced tail phosphorylation of hepatocellular S6 kinase: evidence for a dual involvement of the AMP-activated protein kinase in S6 kinase regulation.
    Møller MT; Samari HR; Seglen PO
    Toxicol Sci; 2004 Dec; 82(2):628-37. PubMed ID: 15342961
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activation of AMP-activated protein kinase inhibits protein synthesis associated with hypertrophy in the cardiac myocyte.
    Chan AY; Soltys CL; Young ME; Proud CG; Dyck JR
    J Biol Chem; 2004 Jul; 279(31):32771-9. PubMed ID: 15159410
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Leucine stimulates mammalian target of rapamycin signaling in C2C12 myoblasts in part through inhibition of adenosine monophosphate-activated protein kinase.
    Du M; Shen QW; Zhu MJ; Ford SP
    J Anim Sci; 2007 Apr; 85(4):919-27. PubMed ID: 17178807
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Control of p70 ribosomal protein S6 kinase and acetyl-CoA carboxylase by AMP-activated protein kinase and protein phosphatases in isolated hepatocytes.
    Krause U; Bertrand L; Hue L
    Eur J Biochem; 2002 Aug; 269(15):3751-9. PubMed ID: 12153572
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acetaldehyde promotes rapamycin-dependent activation of p70(S6K) and glucose uptake despite inhibition of Akt and mTOR in dopaminergic SH-SY5Y human neuroblastoma cells.
    Fang CX; Yang X; Sreejayan N; Ren J
    Exp Neurol; 2007 Jan; 203(1):196-204. PubMed ID: 16962100
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lipid-induced mTOR activation in rat skeletal muscle reversed by exercise and 5'-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside.
    Rivas DA; Yaspelkis BB; Hawley JA; Lessard SJ
    J Endocrinol; 2009 Sep; 202(3):441-51. PubMed ID: 19574345
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Suppression of AMP-activated protein kinase reverses osteoprotegerin-induced inhibition of osteoclast differentiation by reducing autophagy.
    Tong X; Zhang C; Wang D; Song R; Ma Y; Cao Y; Zhao H; Bian J; Gu J; Liu Z
    Cell Prolif; 2020 Jan; 53(1):e12714. PubMed ID: 31696568
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MicroRNA-451 regulates AMPK/mTORC1 signaling and fascin1 expression in HT-29 colorectal cancer.
    Chen MB; Wei MX; Han JY; Wu XY; Li C; Wang J; Shen W; Lu PH
    Cell Signal; 2014 Jan; 26(1):102-9. PubMed ID: 23899558
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phosphatidylinositol 3-kinase (PI-3K)/Akt but not PI-3K/p70 S6 kinase signaling mediates IGF-1-promoted lens epithelial cell survival.
    Chandrasekher G; Sailaja D
    Invest Ophthalmol Vis Sci; 2004 Oct; 45(10):3577-88. PubMed ID: 15452065
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TOR action in mammalian cells and in Caenorhabditis elegans.
    Long X; Müller F; Avruch J
    Curr Top Microbiol Immunol; 2004; 279():115-38. PubMed ID: 14560955
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of AICAR and exercise on insulin-stimulated glucose uptake, signaling, and GLUT-4 content in rat muscles.
    Jessen N; Pold R; Buhl ES; Jensen LS; Schmitz O; Lund S
    J Appl Physiol (1985); 2003 Apr; 94(4):1373-9. PubMed ID: 12496137
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ALA-PDT suppressed the cell growth by Akt-/Erk-mTOR-p70 s6k pathway in human SZ95 sebocytes in vitro.
    Liu W; Wang Q; Tuo J; Chang Y; Ying J; Jiang M; Zouboulis CC; Xiang L
    Photodiagnosis Photodyn Ther; 2018 Dec; 24():1-6. PubMed ID: 29964224
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of the phosphatidylinositol 3-kinase/Akt and mTOR/P70S6-kinase pathways in the proliferation and apoptosis in multiple myeloma.
    Pene F; Claessens YE; Muller O; Viguié F; Mayeux P; Dreyfus F; Lacombe C; Bouscary D
    Oncogene; 2002 Sep; 21(43):6587-97. PubMed ID: 12242656
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PARP-1 promotes autophagy via the AMPK/mTOR pathway in CNE-2 human nasopharyngeal carcinoma cells following ionizing radiation, while inhibition of autophagy contributes to the radiation sensitization of CNE-2 cells.
    Chen ZT; Zhao W; Qu S; Li L; Lu XD; Su F; Liang ZG; Guo SY; Zhu XD
    Mol Med Rep; 2015 Aug; 12(2):1868-76. PubMed ID: 25872765
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 5-aminoimidazole-4-carboxamide ribonucleoside. A specific method for activating AMP-activated protein kinase in intact cells?
    Corton JM; Gillespie JG; Hawley SA; Hardie DG
    Eur J Biochem; 1995 Apr; 229(2):558-65. PubMed ID: 7744080
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adenosine monophosphate-activated protein kinase suppresses vascular smooth muscle cell proliferation through the inhibition of cell cycle progression.
    Igata M; Motoshima H; Tsuruzoe K; Kojima K; Matsumura T; Kondo T; Taguchi T; Nakamaru K; Yano M; Kukidome D; Matsumoto K; Toyonaga T; Asano T; Nishikawa T; Araki E
    Circ Res; 2005 Oct; 97(8):837-44. PubMed ID: 16151020
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.